The global surgical stapling devices market is anticipated to grow to $67,975 million by 2027, at a CAGR of 7.20% between 2019 and 2027. A surgical stapler is a medicinal device, which is generally used during a medical process. These devices are highly efficient and versatile and have progressive security restrictions to overcome post-operative difficulties that often happen due to staple line leakages. The following factors primarily drive the surgical stapling devices market:

• Increasing neurological diseases
• The growing alteration from open to MI practices
• Increasing practice of surgical stapling devices in bariatric operations
• Rising cancer incidence

The important drivers enhancing the growth of the global surgical stapling devices market are increasing neurological diseases and rising cancer incidence. The incidence of prolonged illnesses such as orthopedic, cardiovascular, and neurological diseases is growing worldwide. The rising incidence of cancer is anticipated to boost the surgical stapling devices market. Lung cancer is one of the leading causes of death worldwide. This indicates the huge scope of expansion for the therapeutics segment of cancer over the forecast period.

The products of surgical stapling devices market are used extensively for various purposes. The powered surgical stapling devices market is growing at a faster growth rate and is expected to increase further with sales of new powered surgical stapling devices during the forecast period. Most vendors are focusing on developing next-generation surgical staplers. Manual surgical staplers are most commonly used for skin sutures (general surgeries) and emergency cases. Manual surgical staplers are categorized into different variants and are widely used by surgeons who have less surgical experience. The manual surgical staplers are used in all types of surgeries for end-to-end anastomosis of the tissue. The surgical staplers are available in different sizes, shapes, and designs for specific applications.

The high cost of operations and strict government policies are the major factors hindering the surgical stapling devices market. Interventional surgeries and other surgeries are high cost. The cost of drugs, anesthesia, hospital stay, and other expenses make them even more costly. In developed nations such as the US, the average CABG surgeries cost is quite high. The government policies of the nations may affect the growth of the cardiology market. The safety and security of the patient are considered to be most important. Several procedures adopted by some countries are not allowed in other countries. For example, critical minimally invasive surgeries through robots are performed in the US.

The global surgical stapling devices market segments include products, usage, and end-users.

Products are sub-segmented into:

• Manual surgical stapling devices
• Powered surgical stapling devices

Usages are sub-segmented into:

• Reusable surgical stapling devices
• Disposable surgical stapling devices

End-users are sub-segmented into:

• Hospitals
• Ambulatory Surgery Centers (ASC)

This report covers the present market conditions and the development forecasts of the surgical stapling devices market for 2019-2027 and considered the revenue generated through the sales of surgical stapling devices for products, usage, and end-users to compute the market size by considering 2018 as the base year.

Geographically, the global surgical stapling devices (EAP) market has been segmented on the basis of four major regions, which include:

• North America – The United States and Canada
• Asia-Pacific – India, China, Japan, Australia, South Korea and Rest of APAC
• Europe – The United Kingdom, France, Germany, Spain, Italy and Rest of Europe
• Rest of World- Latin America and Middle-East Asia and Africa

The surgical stapling devices market in North America is expected to hold the largest share by 2027 possibilities of the increasing incidence of gastrointestinal disorders and chronic diseases such as colon cancer, rectal cancer, and severe abdominal diseases. Another reason for the high growth is the rapid shift from inpatient surgical therapy to outpatient surgical procedures with technologically advanced devices offered by leading vendors in the market. The market in North America is likely to shift from electric powered surgical staplers to battery powered surgical staplers. This is due to the increased advantages such as the ease of use and improved mobility.

On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the surgical stapling devices market. APAC is the fastest growing region in the global surgical stapling devices market due to large patient pool requiring MI and other general surgeries.

APAC presents significant opportunities for vendors to expand their position in the market. The economies of emerging countries such as China, India, and Thailand are fast growing. Japan is the leading country in APAC, and the surgical stapler devices market is driven by the rise in the shift from open surgeries to MI surgeries.

The surgical stapling devices market is segmented based on usages which are sub-divided into disposable surgical stapling devices and reusable surgical stapling devices and also segmented on the basis of the end-user, which is further sub-divided into ASC and hospitals. Disposable surgical stapling devices have a disposable cartridge.

Linear staplers are used in thoracic surgery, pediatric surgery, abdominal surgery, and gynecology. Reusable surgical stapling devices are made of stainless steel, which can be autoclaved. These devices use a disposable cartridge, and the equipment is sterilized after each use. Reusable surgical staplers generate less surgical waste; however, energy is required to sterilize the reusable surgical staplers.

ASCs conduct surgeries in outpatient settings, which help patients, save on the cost and duration of the treatment. Hospitals such as multi-specialty hospitals and hospital groups work under government sponsorship or through private entities.

The major market players in the global surgical stapling devices market are:

• Ethicon Inc.
• ConMed
• Dextera Surgical
• Grena
• Medtronic

Company profiles cover the analysis of important players. Ethicon Inc. is one of the world’s leading healthcare and consumer goods companies and is a subsidiary of Johnson & Johnson. It operates in three major business segments: medical devices and diagnostics, pharmaceuticals, and consumer products. The MI segment falls under its subsidiary Ethicon Inc. and is the leading company in the global surgical stapling devices market.

Medtronic is among the world’s largest medical equipment development companies. Medtronic, Inc. manufactures and sells device-based medical therapies. The company also offers products for biologic products; trauma, bone graft substitutes, and drug delivery systems and implantable neurostimulator therapies for the treatment of chronic movement, pain, movement disorder, obsessive-compulsive, fecal incontinence.

Key Findings of the global surgical stapling devices market:

• Powered surgical stapling devices are the fastest growing products
• Reusable surgical stapling holds the largest market share in terms of usage
• Ambulatory surgery centers (ASC) are the fastest growing end-user